Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
US GSK Clinical Trials Call Center
CONTACT
EU GSK Clinical Trials Call Center
CONTACT
Lead
35Pharma Inc., a GSK company
A Phase 1b/2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of the Activin Signaling Inhibitor HS235 Added to Background Treatment in Adults with Pulmonary Arterial Hypertension (PAH)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted